Literature DB >> 17986796

Goals of dyslipidemia management.

Tamio Teramoto, Jun Sasaki, Hirotsugu Ueshima, Genshi Egusa, Makoto Kinoshita, Kazuaki Shimamoto, Hiroyuki Daida, Sadatoshi Biro, Kazuhiko Hirobe, Tohru Funahashi, Koutaro Yokote, Masayuki Yokode.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17986796     DOI： 10.5551/jat.e554

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  6 in total

Review 1.  Efficacy and safety of pitavastatin versus simvastatin: a meta-analysis of randomized controlled trials.

Authors:  Zhen Jiang; Ren Rong Gong; Li Qiu; Qian Wang; Mi Su; Xiao Juan Liu; Min Shan Hu; Jia Lin; Ding Zhi Fang
Journal:  Clin Drug Investig       Date:  2014-09       Impact factor: 2.859

2.  Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Li Shen; Hongchun Peng; Ran Peng; Qingsong Fan; Shuiping Zhao; Danyan Xu; Christophe Morisseau; Nipavan Chiamvimonvat; Bruce D Hammock
Journal:  Atherosclerosis       Date:  2015-02-16       Impact factor: 5.162

Review 3.  Soluble epoxide hydrolase in atherosclerosis.

Authors:  Yi-Xin Jim Wang; Arzu Ulu; Le-Ning Zhang; Bruce Hammock
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

4.  A Randomized Controlled Study to Compare the Effects of Rosuvastatin 2.5 mg and Pravastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-1).

Authors:  Tsutomu Yamazaki; Masahiko Kurabayashi
Journal:  Ann Vasc Dis       Date:  2010-03-29

5.  The characteristics of dyslipidemia patients with different durations in Beijing: a cross-sectional study.

Authors:  Yingying Liu; Puhong Zhang; Wei Wang; Huan Wang; Ling Zhang; Wei Wu; Xiuhua Guo
Journal:  Lipids Health Dis       Date:  2010-10-13       Impact factor: 3.876

6.  Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.

Authors:  Ichiro Tatsuno; Kentarou Kudou; Tomoya Kagawa
Journal:  Cardiovasc Ther       Date:  2015-12       Impact factor: 3.023
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.